Characteristic findings of microvascular dysfunction on coronary computed tomography angiography in patients with intermediate coronary stenosis.


Journal

European radiology
ISSN: 1432-1084
Titre abrégé: Eur Radiol
Pays: Germany
ID NLM: 9114774

Informations de publication

Date de publication:
Dec 2021
Historique:
received: 27 08 2020
accepted: 18 03 2021
revised: 19 02 2021
pubmed: 20 5 2021
medline: 17 11 2021
entrez: 19 5 2021
Statut: ppublish

Résumé

We aimed to assess the prevalence of coexistence of coronary microvascular dysfunction (CMD) in patients with intermediate epicardial stenosis and to explore coronary computed tomography angiography (CCTA)-derived lesion-, vessel-, and cardiac fat-related characteristic findings associated with CMD. A retrospective cross-sectional single-center study included a total of 177 patients with intermediate stenosis in the left anterior descending artery (LAD) who underwent CCTA and invasive physiological measurements. The 320-slice CCTA analysis included qualitative and quantitative assessments of plaque, vessel, epicardial fat volume (ECFV) and epicardial fat attenuation (ECFA), and pericoronary fat attenuation (FAI). CMD was defined by the index of microcirculatory resistance (IMR) ≥ 25. In the entire cohort, median fractional flow reserve (FFR) and median IMR values were 0.77 (0.69-0.84) and 19.0 (13.7-27.7), respectively. The prevalence of CMD was 32.8 % (58/177) in the total cohort. The coexistence of CMD and functionally significant stenosis was 34.3 % (37/108), whereas CMD in nonsignificant intermediate stenosis was 30.4 % (21/69). CMD was significantly associated with greater lumen volume (p = 0.031), greater fibrofatty and necrotic component (FFNC) volume (p = 0.030), and greater ECFV (p = 0.030), but not with FAI (p = 0.832) and ECFA (p = 0.445). On multivariable logistic regression analysis, vessel volume, vessel lumen volume, lesion remodeling index, ECFV, and lesion FFNC volume were independent predictors of CMD. The prevalence of CMD was about one-third in patients with intermediate stenosis in LAD regardless of the presence or absence of functional stenosis significance. The integrated CCTA assessment may help in the identification of CMD. • The coexistence of coronary microvascular dysfunction (CMD) and functionally significant stenosis was 34.3 %, whereas CMD in nonsignificant intermediate stenosis was 30.4 %. • Coronary computed tomography angiography (CCTA)-derived CMD characteristics were vessel volume, vessel lumen volume, remodeling index, epicardial fat volume, and fibrofatty necrotic core volume. • Integrated CCTA assessment may help identify the coexistence of CMD and epicardial stenosis.

Identifiants

pubmed: 34009414
doi: 10.1007/s00330-021-07909-7
pii: 10.1007/s00330-021-07909-7
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

9198-9210

Informations de copyright

© 2021. European Society of Radiology.

Références

Gupta A, Taqueti VR, van de Hoef TP et al (2017) Integrated noninvasive physiological assessment of coronary circulatory function and impact on cardiovascular mortality in patients with stable coronary artery disease. Circulation 136:2325–2336
doi: 10.1161/CIRCULATIONAHA.117.029992
Taqueti VR, Hachamovitch R, Murthy VL et al (2015) Global coronary flow reserve is associated with adverse cardiovascular events independently of luminal angiographic severity and modifies the effect of early revascularization. Circulation 131:19–27
doi: 10.1161/CIRCULATIONAHA.114.011939
Ziadi MC, Dekemp RA, Williams KA et al (2011) Impaired myocardial flow reserve on rubidium-82 positron emission tomography imaging predicts adverse outcomes in patients assessed for myocardial ischemia. J Am Coll Cardiol 58:740–748
doi: 10.1016/j.jacc.2011.01.065
Jespersen L, Hvelplund A, Abildstrom SZ et al (2012) Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. Eur Heart J 33:734–744
doi: 10.1093/eurheartj/ehr331
Maddox TM, Stanislawski MA, Grunwald GK et al (2014) Nonobstructive coronary artery disease and risk of myocardial infarction. JAMA 312:1754–1763
doi: 10.1001/jama.2014.14681
Mathew RC, Bourque JM, Salerno M, Kramer CM (2020) Cardiovascular imaging techniques to assess microvascular dysfunction. JACC Cardiovasc Imaging 13:1577–1590
doi: 10.1016/j.jcmg.2019.09.006
SCOT-HEART investigators (2015) CT coronary angiography in patients with suspected angina due to coronary heart disease (SCOT-HEART): an open-label, parallel-group, multicentre trial. Lancet 385:2383–2391
Douglas PS, Hoffmann U, Patel MR et al (2015) Outcomes of anatomical versus functional testing for coronary artery disease. N Engl J Med 372:1291–1300
doi: 10.1056/NEJMoa1415516
Versteylen MO, Kietselaer BL, Dagnelie PC et al (2013) Additive value of semiautomated quantification of coronary artery disease using cardiac computed tomographic angiography to predict future acute coronary syndrome. J Am Coll Cardiol 61:2296–2305
doi: 10.1016/j.jacc.2013.02.065
Ovrehus KA, Gaur S, Leipsic J et al (2018) CT-based total vessel plaque analyses improves prediction of hemodynamic significance lesions as assessed by fractional flow reserve in patients with stable angina pectoris. J Cardiovasc Comput Tomogr 12:344–349
doi: 10.1016/j.jcct.2018.04.008
Lee SE, Park HB, Xuan D et al (2019) Consistency of quantitative analysis of coronary computed tomography angiography. J Cardiovasc Comput Tomogr 13:48–54
doi: 10.1016/j.jcct.2018.09.012
Antonopoulos AS, Sanna F, Sabharwal N et al (2017) Detecting human coronary inflammation by imaging perivascular fat. Sci Transl Med. https://doi.org/10.1126/scitranslmed.aal2658
Oikonomou EK, Marwan M, Desai MY et al (2018) Non-invasive detection of coronary inflammation using computed tomography and prediction of residual cardiovascular risk (the CRISP CT study): a post-hoc analysis of prospective outcome data. Lancet 392:929–939
doi: 10.1016/S0140-6736(18)31114-0
Ford TJ, Ong P, Sechtem U et al (2020) Assessment of vascular dysfunction in patients without obstructive coronary artery disease: why, how, and when. JACC Cardiovasc Interv 13:1847–1864
doi: 10.1016/j.jcin.2020.05.052
Taylor AJ, Cerqueira M, Hodgson JM et al (2010) ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010 appropriate use criteria for cardiac computed tomography. A report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the Society of Cardiovascular Computed Tomography, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the American Society of Nuclear Cardiology, the North American Society for Cardiovascular Imaging, the Society for Cardiovascular Angiography and Interventions, and the Society for Cardiovascular Magnetic Resonance. J Am Coll Cardiol 56:1864–1894
doi: 10.1016/j.jacc.2010.07.005
Leipsic J, Abbara S, Achenbach S et al (2014) SCCT guidelines for the interpretation and reporting of coronary CT angiography: a report of the Society of Cardiovascular Computed Tomography Guidelines Committee. J Cardiovasc Comput Tomogr 8:342–358
doi: 10.1016/j.jcct.2014.07.003
Maurovich-Horvat P, Ferencik M, Voros S, Merkely B, Hoffmann U (2014) Comprehensive plaque assessment by coronary CT angiography. Nat Rev Cardiol 11:390–402
doi: 10.1038/nrcardio.2014.60
Motoyama S, Ito H, Sarai M et al (2015) Plaque characterization by coronary computed tomography angiography and the likelihood of acute coronary events in mid-term follow-up. J Am Coll Cardiol 66:337–346
doi: 10.1016/j.jacc.2015.05.069
Lee JM, Choi KH, Koo BK et al (2019) Prognostic implications of plaque characteristics and stenosis severity in patients with coronary artery disease. J Am Coll Cardiol 73:2413–2424
doi: 10.1016/j.jacc.2019.02.060
Chang HJ, Lin FY, Lee SE et al (2018) Coronary atherosclerotic precursors of acute coronary syndromes. J Am Coll Cardiol 71:2511–2522
doi: 10.1016/j.jacc.2018.02.079
Heo R, Park HB, Lee BK et al (2016) Optimal boundary detection method and window settings for coronary atherosclerotic plaque volume analysis in coronary computed tomography angiography: comparison with intravascular ultrasound. Eur Radiol 26:3190–3198
doi: 10.1007/s00330-015-4121-5
Park HB, Lee BK, Shin S et al (2015) Clinical feasibility of 3D automated coronary atherosclerotic plaque quantification algorithm on coronary computed tomography angiography: comparison with intravascular ultrasound. Eur Radiol 25:3073–3083
doi: 10.1007/s00330-015-3698-z
Nakazato R, Shalev A, Doh JH et al (2013) Aggregate plaque volume by coronary computed tomography angiography is superior and incremental to luminal narrowing for diagnosis of ischemic lesions of intermediate stenosis severity. J Am Coll Cardiol 62:460–467
doi: 10.1016/j.jacc.2013.04.062
Gaur S, Ovrehus KA, Dey D et al (2016) Coronary plaque quantification and fractional flow reserve by coronary computed tomography angiography identify ischaemia-causing lesions. Eur Heart J 37:1220–1227
doi: 10.1093/eurheartj/ehv690
Oda S, Utsunomiya D, Funama Y et al (2016) Effect of iterative reconstruction on variability and reproducibility of epicardial fat volume quantification by cardiac CT. J Cardiovasc Comput Tomogr 10:150–155
doi: 10.1016/j.jcct.2015.10.006
Yong AS, Layland J, Fearon WF et al (2013) Calculation of the index of microcirculatory resistance without coronary wedge pressure measurement in the presence of epicardial stenosis. JACC Cardiovasc Interv 6:53–58
doi: 10.1016/j.jcin.2012.08.019
Lee JM, Layland J, Jung JH et al (2015) Integrated physiologic assessment of ischemic heart disease in real-world practice using index of microcirculatory resistance and fractional flow reserve: insights from the International Index of Microcirculatory Resistance Registry. Circ Cardiovasc Interv. https://doi.org/10.1161/CIRCINTERVENTIONS.115.002857
Stenstrom I, Maaniitty T, Uusitalo V et al (2017) Frequency and angiographic characteristics of coronary microvascular dysfunction in stable angina: a hybrid imaging study. Eur Heart J Cardiovasc Imaging 18:1206–1213
doi: 10.1093/ehjci/jex193
Ford TJ, Stanley B, Good R et al (2018) Stratified medical therapy using invasive coronary function testing in angina: the CorMicA trial. J Am Coll Cardiol 72:2841–2855
doi: 10.1016/j.jacc.2018.09.006
Crea F, Camici PG, Bairey Merz CN (2014) Coronary microvascular dysfunction: an update. Eur Heart J 35:1101–1111
doi: 10.1093/eurheartj/eht513
Camici PG, d’Amati G, Rimoldi O (2015) Coronary microvascular dysfunction: mechanisms and functional assessment. Nat Rev Cardiol 12:48–62
doi: 10.1038/nrcardio.2014.160
Taqueti VR, Di Carli MF (2018) Coronary microvascular disease pathogenic mechanisms and therapeutic options: JACC state-of-the-art review. J Am Coll Cardiol 72:2625–2641
doi: 10.1016/j.jacc.2018.09.042
Siasos G, Sara JD, Zaromytidou M et al (2018) Local low shear stress and endothelial dysfunction in patients with nonobstructive coronary atherosclerosis. J Am Coll Cardiol 71:2092–2102
doi: 10.1016/j.jacc.2018.02.073
Vergallo R, Papafaklis MI, Yonetsu T et al (2014) Endothelial shear stress and coronary plaque characteristics in humans: combined frequency-domain optical coherence tomography and computational fluid dynamics study. Circ Cardiovasc Imaging 7:905–911
doi: 10.1161/CIRCIMAGING.114.001932
Yamamoto E, Siasos G, Zaromytidou M et al (2017) Low endothelial shear stress predicts evolution to high-risk coronary plaque phenotype in the future: a serial optical coherence tomography and computational fluid dynamics study. Circ Cardiovasc Interv. https://doi.org/10.1161/CIRCINTERVENTIONS.117.005455
Milanese G, Silva M, Ledda RE et al (2020) Validity of epicardial fat volume as biomarker of coronary artery disease in symptomatic individuals: results from the ALTER-BIO registry. Int J Cardiol 314:20–24
doi: 10.1016/j.ijcard.2020.04.031
Nappi C, Ponsiglione A, Acampa W et al (2019) Relationship between epicardial adipose tissue and coronary vascular function in patients with suspected coronary artery disease and normal myocardial perfusion imaging. Eur Heart J Cardiovasc Imaging 20:1379–1387
doi: 10.1093/ehjci/jez182
Fearon WF, Balsam LB, Farouque HM et al (2003) Novel index for invasively assessing the coronary microcirculation. Circulation 107:3129–3132
doi: 10.1161/01.CIR.0000080700.98607.D1
Lee BK, Lim HS, Fearon WF et al (2015) Invasive evaluation of patients with angina in the absence of obstructive coronary artery disease. Circulation 131:1054–1060
doi: 10.1161/CIRCULATIONAHA.114.012636
Kobayashi Y, Lee JM, Fearon WF et al (2017) Three-vessel assessment of coronary microvascular dysfunction in patients with clinical suspicion of ischemia: prospective observational study with the index of microcirculatory resistance. Circ Cardiovasc Interv. https://doi.org/10.1161/CIRCINTERVENTIONS.117.005445
Echavarria-Pinto M, van de Hoef TP, Nijjer S et al (2017) Influence of the amount of myocardium subtended to a coronary stenosis on the index of microcirculatory resistance. Implications for the invasive assessment of microcirculatory function in ischaemic heart disease. EuroIntervention 13:944–952
doi: 10.4244/EIJ-D-16-00525
Murai T, Lee T, Yonetsu T et al (2013) Variability of microcirculatory resistance index and its relationship with fractional flow reserve in patients with intermediate coronary artery lesions. Circ J 77:1769–1776
doi: 10.1253/circj.CJ-12-1442
Sugiyama T, Kanaji Y, Hoshino M et al (2020) Determinants of pericoronary adipose tissue attenuation on computed tomography angiography in coronary artery disease. J Am Heart Assoc. https://doi.org/10.1161/JAHA.120.016202

Auteurs

Masahiro Hoshino (M)

Division of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital, 4-1-1 Otsuno, Tsuchiura City, Ibaraki, 300-0028, Japan.

Seokhun Yang (S)

Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul, South Korea.

Tomoyo Sugiyama (T)

Division of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital, 4-1-1 Otsuno, Tsuchiura City, Ibaraki, 300-0028, Japan.

Jinlong Zhang (J)

Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul, South Korea.

Yoshihisa Kanaji (Y)

Division of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital, 4-1-1 Otsuno, Tsuchiura City, Ibaraki, 300-0028, Japan.

Rikuta Hamaya (R)

Division of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital, 4-1-1 Otsuno, Tsuchiura City, Ibaraki, 300-0028, Japan.
Harvard T.H. Chan School of Public Health, Boston, MA, USA.

Masao Yamaguchi (M)

Division of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital, 4-1-1 Otsuno, Tsuchiura City, Ibaraki, 300-0028, Japan.

Masahiro Hada (M)

Division of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital, 4-1-1 Otsuno, Tsuchiura City, Ibaraki, 300-0028, Japan.

Tomoki Horie (T)

Division of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital, 4-1-1 Otsuno, Tsuchiura City, Ibaraki, 300-0028, Japan.

Kai Nogami (K)

Division of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital, 4-1-1 Otsuno, Tsuchiura City, Ibaraki, 300-0028, Japan.

Hiroki Ueno (H)

Division of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital, 4-1-1 Otsuno, Tsuchiura City, Ibaraki, 300-0028, Japan.

Toru Misawa (T)

Division of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital, 4-1-1 Otsuno, Tsuchiura City, Ibaraki, 300-0028, Japan.

Taishi Yonetsu (T)

Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Tokyo, Japan.

Doyeon Hwang (D)

Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul, South Korea.

Joo Myung Lee (JM)

Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul, South Korea.

Eun-Seok Shin (ES)

Department of Cardiology, Ulsan Medical Center, Ulsan Hospital, Ulsan, South Korea.

Joon-Hyung Doh (JH)

Department of Medicine, Inje University Ilsan Paik Hospital, Goyang, South Korea.

Chang-Wook Nam (CW)

Department of Medicine, Keimyung University Dongsan Medical Center, Daegu, South Korea.

Bon-Kwon Koo (BK)

Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul, South Korea.

Tetsuo Sasano (T)

Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Tokyo, Japan.

Tsunekazu Kakuta (T)

Division of Cardiovascular Medicine, Tsuchiura Kyodo General Hospital, 4-1-1 Otsuno, Tsuchiura City, Ibaraki, 300-0028, Japan. kaz@joy.email.ne.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH